Simbec-Orion Hosts Successful Symposia at British Embassy in Copenhagen


Attendees from selected biotechnology companies from across the Nordic region were welcomed by the Simbec-Orion team at our symposium hosted at the British Embassy in Copenhagen on 16 May, supported by the UK’s Department of International Trade (DIT). The ‘Clinical Development Plans for Rare Disease and Oncology Therapies to Improve your Net Present Value’ symposium [...]

Orphan Drug Designation (ODD): Meeting The Unmet Need


If you missed our live Orphan Drug Designation (ODD) webinar you can view on demand now. Achieving ODD status, is a significant step enabling your product to be licensed faster, cost-efficiently, and achieve market exclusivity for 10 years. Join this 1-hour webinar where the audience will gain a practical overview in the steps to achieve [...]

Come Talk To Us at World Orphan Drug Congress, USA, 25 – 27 April


Meet the team Douglas Cookson, SVP Commercial Development, Simbec-Orion Group Dani Hristova, Associate Medical Director, Orion Clinical Jeff Trickett, Director Business Development, Simbec-Orion Group Steve Novak, Director Business Development, Simbec-Orion Group